Cinitapride protects against ethanol-lnduced gastric mucosal injury in rats: Role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds

Pharmacology

Volumn 54, Issue 4, 1997, Pages 193-202

  Alarcon Dela Lastra Romero C ^a   Lopez A ^a   Martin M J ^a   la Casa, C ^a   Motilva, V ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

5 Hydroxytryptamine; Cinitapride; Gastric mucus; Gastric ulceration; Prostaglandins; Sulfhydryl compounds

Indexed keywords

ALCOHOL; BENZAMIDE DERIVATIVE; CINITAPRIDE; GLYCOPROTEIN; HEXOSAMINE; PROSTAGLANDIN; PROSTAGLANDIN E2; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; THIOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER;

ANIMALS; BENZAMIDES; CELL SURVIVAL; ETHANOL; GASTRIC MUCOSA; PROSTAGLANDINS; RATS; RATS, WISTAR; SEROTONIN; SULFHYDRYL COMPOUNDS;

EID: 1842406021     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139487     Document Type: Article

References (40)

1. C'ho CH. Mettrick DI: Circadium variation in the distribution of Hy-menolepis diminuta (ccstoda) and 5-hydroxytryptamine levels in the gastrointestinal tract of the laboratory rat. Parasitology 1982:84:431-441.
2. Perdue MH. McKay DM: Immuno-modulation of gastrointestinal epithelium; in Wallace IL (cd): Immu-nopharmacology of the Gastrointestinal System. New York, Academic Press. 1993. pp 15-39.
3. Cho CH. Ogle CW: The inhibitory action of 5-hydroxytryptaminc on gastric secretory function in rats. Br J Pharmacol 1986;87:371-377.
4. Canfield SP. Spencer JE: The inhibitory effects of 5-hydroxytryptaminc on gastric acid secretion by the rat isolated stomach. Br J Pharmacol 1983;78:123-129.
5. Giorgio GM. Primetto M. Lucia M. Giorgio S: Protection by 2-methyl-triazolidine-4-carboxylic acid by serotonin ulcer of the rat stomach. IRCS Med Sci 1985. pp 1066-1067.
6. Goto Y, Nagata T. Nagai T, Wata-nabe K: Serotonin-induced mucosal lesions in the rat as experimental ulcer model: Significance of vasoactive factors. Gastroenterology 1986: 90:1435-1437.
7. Wong SH. Cho CH. Ogle CW: The role of serotonin in ethanol-induced gastric glandular damage in rats. Digestion 1990:45:52-60.
8. Kerrigan DD. Taylor ME. Read NW, Johnson AD: Acid motility and ulcers: A comparison of cisapride with placebo in the prevention of duodenal ulcer relapse. Gut 1993; 34:1042-1046.
9. Glavin GB, Zsabo S: Experimental gastric mucosal injury: Laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies. Fed Am Soc Biol J 1992;6:825-830.
10. Lopez A. Motilva V. Alarcon dc la Lastra C. Martin M J, La Casa C: The role of gastric mucosal sulphy-dryls in the ulcer-protecting effects of cisapride. J Pharm Pharmacol 1996;48:37-40.
11. Wiseman LR, Faulds D: Cisapride: An updated review of its pharmacology and therapeutic efficacy as a prokinctic agent in gastrointestinal motility disorders. Durgs 1994:47: 116-152.
12. Fernandez AG, Puig J. Bou J, Berga P, Cristwood RW. Bloxham D. Roberts DJ: Cinitapride induced contractions and acetylcholine release in resting guinea-pig myenteric plexus-longitudinal muscle preparation are mediated by activation of 5-HT4 receptors. J Gastrointest Motil 1990:2:141.
13. Cho CH. Chen BW: Endogenous prostaglandins: Its role in gastric mucosal blood flow and ethanol ulceration in rats. Prostaglandins 1990:40:397-402.
14. Loguerio C, Romano M. Di Sapio M, Nardi G, Taranto D. Grella A: Regional variations in total and non-protein sulphydryl compounds in the human gastric mucosa and effects of ethanol. Scand J Gastroenterol 1991:26:1042-1048.
15. Alarcon dc la Lastra C. Lopez A. Molilva V: Gastroprotection and prostaglandin Ej generation in rats by flavonoids of Diltrichiu vise osa. Planta Med 1993:59:497-501.
16. Lowry OD, Rosebrough NJ. Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951:193:265-275.
17. Boas NF: Method for the determination of hexosantines in tissues. J Biol Chem 1953;204:253-263.
18. Escolar G. Navarro G, Scndros S. Bulbcna O: Effect of cold-restraint stress and zinc acexamate on gastric mucus production in intact glands. Arch Int Pharmacodyn 1987:290: 128-137.
19. Vane JR: Inhibition of prostaglandins synthesis, a mechanism of aspi-rin-likedrug. Nature 1971:231:232-235.
20. Konturek SJ. Rodeki T. Piastucki J. Drozdowicz D: Advances in the understanding of the mechanism of cy-toprotective action by colloidal bismuth subcitratc. Scand J Gastroenterol 1986;112:6-10.
21. Navarro C. Escolar G. Banos JE. Casanovas CJ, Bulbcna O: Effect of zinc acexamate on gastric mucosal production of prostaglandin F.? in normal and stressed rats. Prostaglandins Leukot Esscnt Fatty Acids 1988:33:75-80.
22. Garg GP. Cho CH. Ogle CW: The role of gastric mucosal sulphydryls in the ulcer-protecting effects of sul-phasalazine. J Pharrn Pharmacol 1991:43:733-734.
23. Sedlak J. Lindsay RH: Stimulation of total protein-bound and non-pro-lein sulphydryls groups in tissue with Ellman's reagent. Anal Bio-chem 1968:25:192-205.
24. Jacobson ED: Circulatory' mechanisms of gastric mucosal damage and protection. Gastroenterology 1992:102:1788-1800.
25. Terrano A, Ota S. Hiraishi H, Mu-toh H: Gastric cyloproteclior!: Morphological perspectives. Acta Pathol Jpn 1993;43:2-10.
26. Wilson DE: Cytoprotective therapy. Prostaglandins; in Hollander D, Tarnawski A (eds): Gastric Cytopro-tection. A Clinician's Guide. New York. Plenum. 1989. pp 169-183.
27. Allen A. Flemstrom G. Gamer A, Kivilaakso E: Gastroduodenal mucosal protection. Physiol Rev 1993; 73:823-857.
28. Hogaboam CM. Bissonnette EY. Chin BC. Befus AD. Wallace S: Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993:104: 122-129.
29. Pihan G. Rogers C. Szabo S: Vascular injury in acute gastric mucosal damage. Mediatory role of ieuko-trienes. Dig Dis Sci 1988:33:625-632.
30. Peskar BM. Lange K. Moppet L. Pcskar BA: Ethanol stimulates formation of leukotriene Cj in rat gastric mucosa. Prostaglandins 1986: 31:283-292.
31. Boughton-Smith NK, Whittle BJR: Inhibition by 16,16-dimethyl PGE: of ethanol-induced gastric mucosal damage and leukotriene formation. Prostaglandins 1988:35:945-957.
32. Szabo S: Mechanism of mucosal injury in the stomach and duodenum: Time-sequence analysis of morphology functional, biochemical and his-tochcmical studies. Scand J Gastroenterol 1987;22:21-28.
33. Garrison JC: Histamine, bradyki-nin, 5-hvdroxytryptamine, and their antagonists: in Gilman AG, Rail TW. Nics AS. Taylor P (eds): The Pharmacological Basis of Therapeutics. New York. Pcrgamon, 1991, pp 575-580.
34. Tsukamoto Y, Goto H, Hasc S, Arisawa T, Ohara A. Suzuki T, Hoshino H: Serotonin-induced decrease of duodenal mucosal blood flow plus acid load produces duodenal mucosal lesions in rats. Digestion 1991; 50:99-103.
35. Cho CH. Hua MF. Chou CK, Ho LT: Protection of zinc sucralfate against gastric necrosis induced by ethanol in rats. Proc Natl Sci Count 1983;7:261-267.
36. Cho CH. Qiu BS. Luk CT, Ogle CW: Time-course study on the action of 5-hydroxytryptamine on gastric secretion and mucosal blood flow and on ethanol-induced gastric damage in rats. Digestion 1992;53:79-87.
37. Cho CH. Pang SF. Chen BW. Pfeiffer CJ: Modulating action of melan-tonin on serotonin-induced aggravation of ethanol ulceration and changes of mucosal blood flow in rat stomachs. J Pineal Res 1989:6:89-97.
38. Fernandez AG, Llenas J. Massing-ham R: Estudio de la posible implicación de los distintos subtipos de receptores de 5-HT en el vaciamiento de estómago inducido por fármacos en la rata. Rev Farmacol Clin Exp 1986:3:19-24.
39. Fernandez A, Robert DJ: Cinitapri-da tartrato ácido. Drug 1991; 16:1-13.
40. Llupia J, Fernandez AG, Berga P: Medicación del sistema serotonérgi-co en la actividad farmacológica de cinitaprida. Rev Farmacol Clin Exp 1989:6:255.